Nivolumab + ipilimumab: Added benefit in pleural mesothelioma with non-epithelioid tumour ...

Nivolumab + ipilimumab: Added benefit in pleural mesothelioma with non-epithelioid tumour histology – Medical Dialogues

Nivolumab + ipilimumab: Added benefit in pleural mesothelioma with non-epithelioid tumour histology We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see…

 

Read the full article here


-- END RSP MOD -->